Reuters

A daily version of the pill was first approved by the FDA (news - web sites) in 2003, but the companies never launched the product as they explored a more convenient dosage for the medicine to treat brittle bones.
Boniva, known in Europe as Bonviva, is part of a popular class of drugs known as bisphosphonates that aim to treat post-menopausal women with osteoporosis.

More...

Takeover of Indigenous Garifuna Community Hospital

Menstruation Is Fast Becoming Optional

Rare Disease Traced to Sperm Donor

Crohn's Disease Drug Cleared for Children

5-Month-Old Girls in ICU After Separation

Coroner: Peanut Kiss Didn't Cause Death

Feds Probe Kidney Transplant Program

Supermarkets Urge Families to Dinner Table